Caisse de Depot et Placement du Quebec (CDPQ)’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-12,000
Closed -$880K 584
2022
Q4
$880K Buy
+12,000
New +$903K ﹤0.01% 513

Other funds holding NVCR

Caisse de Depot et Placement du Quebec (CDPQ)'s NVCR Position: Q1 2023 in Review

Caisse de Depot et Placement du Quebec (CDPQ) sold out of NovoCure (NVCR) in Q1 2023, closing a stake of 12,000 shares — an estimated $880K sold.

Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in NVCR in Q4 2022 and held it in 1 quarter. The position peaked at $880K in Q4 2022. 295 funds tracked by Wall St. Rank hold NVCR as of Q1 2023.

  • Caisse de Depot et Placement du Quebec (CDPQ) reported no remaining NovoCure position as of Q1 2023 after selling out during the quarter.
  • Caisse de Depot et Placement du Quebec (CDPQ) sold 12,000 NovoCure shares in Q1 2023, an estimated $880K.
  • Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in NovoCure in Q4 2022 and held it in 1 quarter.
  • Caisse de Depot et Placement du Quebec (CDPQ)'s NovoCure position peaked at $880K in Q4 2022.
  • 295 funds tracked by Wall St. Rank held NovoCure as of Q1 2023.

Based on Caisse de Depot et Placement du Quebec (CDPQ)'s 13F filing for Q1 2023, filed 12 May 2023.